5590076609 · Annan allmän öppen hälso- och sjukvård, ej primärvård · BORLÄNGE
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
In 2026, net sales rose 29.6 % to 14.4 MSEK. Dala Vård & Vaccin AB lifted its operating margin from 1.7 % to 20 % in 2026. The net result has been positive in three consecutive comparable periods, from 2024 to 2026. Cash holdings amounted to roughly 57.4 % of total assets for 2026.
Calculated by ArkivNord from filed annual reports. About the methodology
Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge.
Net revenue
14.4 MSEK
▲ +30%Net result
2.9 MSEK
▲ >+1000%Employees
4
▼ −20%Per the signatures in the annual report for the fiscal year ending 2026-04-30.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
arkivnord